Cargando…
Natural compounds from botanical drugs targeting mTOR signaling pathway as promising therapeutics for atherosclerosis: A review
Atherosclerosis (AS) is a chronic inflammatory disease that is a major cause of cardiovascular diseases (CVDs), including coronary artery disease, hypertension, myocardial infarction, and heart failure. Hence, the mechanisms of AS are still being explored. A growing compendium of evidence supports t...
Autores principales: | Wu, Qian, Lv, Qianyu, Liu, Xiao’an, Ye, Xuejiao, Cao, Linlin, Wang, Manshi, Li, Junjia, Yang, Yingtian, Li, Lanlan, Wang, Shihan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9894899/ https://www.ncbi.nlm.nih.gov/pubmed/36744254 http://dx.doi.org/10.3389/fphar.2023.1083875 |
Ejemplares similares
-
Effects of PCSK9 inhibitors on coronary microcirculation, inflammation and cardiac function in patients with CHD after PCI: a protocol for systematic review and meta-analysis
por: Ye, Xuejiao, et al.
Publicado: (2023) -
Dietary sodium, potassium intake, sodium-to-potassium ratio and risk of hypertension: a protocol for systematic review and dose–response meta-analysis of cohort studies
por: Yang, Yingtian, et al.
Publicado: (2023) -
Storax, A Promising Botanical Medicine for Treating Cardio-Cerebrovascular Diseases: A Review
por: Xu, Zhuo, et al.
Publicado: (2021) -
Modulating mTOR Signaling as a Promising Therapeutic Strategy for Atherosclerosis
por: Poznyak, Anastasia V., et al.
Publicado: (2022) -
Commentary: Overcoming mTOR resistance mutations with a new-generation mTOR inhibitor
por: Renna, Maurizio
Publicado: (2016)